Table 3 Effects of AEE on potential biomarkers associated with atherosclerosis in urine.

From: UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters

No.

RT

VIP

Formula

Metabolite

Adduction

m/z

Fold Change

Pathway

HFD/Control

AEE/HFD

1

1.16

1.30

C6H8O7

Citric acid

M−H

191.0191

5.23**

0.73

Citrate cycle

2

4.23

1.58

C9H17NO5

Pantothenic acid

M−H

218.1017

0.07**

0.74

beta-Alanine metabolism

3

6.05

2.88

C12H14O7

Phenylglucuronide

M−H

269.0654

4.09**

0.93

 

4

6.29

2.54

C6H6O4S

Phenol sulphate

M−H

172.9899

2.54**

0.80*

 

5

6.72

5.00

C9H9NO3

Hippuric acid

M−H

178.0494

0.29**

0.93

Phenylalanine metabolism

6

7.09

2.68

C8H7NO4S

Indoxyl sulfate

M−H

212.0007

0.77

0.81

Tryptophan metabolism

7

7.64

2.92

C10H11NO3

Phenylacetylglycine

M−H

192.0650

1.26**

0.88*

Phenylalanine metabolism

8

8.22

3.75

C13H16O7

p-Cresol glucuronide

M−H

283.0811

1.40**

0.88

 

9

8.68

1.95

C9H10O3

Phenyllactic acid

M−H

165.0542

0.25**

0.98

Tropane, piperidine and pyridine alkaloid biosynthesi

10

9.89

1.09

C9H16O4

Azelaic acid

M−H

187.0960

0.38**

0.61**

 

11

1.70

1.40

C6H6N2O

Niacinamide

M+H

123.0555

0.20**

0.57

Nicotinate and nicotinamide metabolism

12

0.88

1.04

C7H19N3

Spermidine

M+H

146.1652

0.33**

0.94

Arginine and proline metabolism

13

1.15

1.35

C6H11NO2

Pipecolic acid

M+H

130.0863

0.34

1.67

Lysine degradation

14

1.14

1.08

C8H17NO2

DL-2-AC

M+H

160.1331

0.27**

0.96

 

15

1.87

1.26

C6H13NO2

Leucine

M+H

132.1018

0.30*

0.71

Valine, leucine and isoleucine degradation

16

7.26

1.22

C17H20N4O6

Riboflavin

M+H

377.1467

0.68**

0.51**

Vitamin digestion and absorption

17

8.74

1.21

C5H9NO3S

Acetylcysteine

M+H

164.0376

2.82**

0.86

 
  1. DL-2-AC: DL-2-Aminooctanoic acid, * P < 0.05, ** P < 0.01.